AARD logo

Aardvark Therapeutics, Inc. (AARD)

Profile

Full Name

Aardvark Therapeutics, Inc.

Ticker

NASDAQ: AARD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 13, 2025

Indexes

Not included

Website

http://aardvarktherapeutics.com

Employees

26

Key Details

Price

$12.17(-3.41%)

Market cap

$263.95M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.96(-72.42% YoY)

PE ratio

-

Next earnings date

Aug 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $12.17
    AARD price is $12.17

    30-Day Relative Volume

    0.59
    AARD 30-day relative volume is 0.59

    Price Performance

    Price Most recent change

    -3.41%
    AARD price was down -3.41% on Jul 11, 2025

    Price YTD change

    -
    AARD price ytd change is unknown

    Price 1-year change

    -
    AARD price 1-year change is unknown

    Price 3-year change

    -
    AARD price 3-year change is unknown

    Price Range

    Price All-time high

    $19.58
    AARD price is currently -37.84% below its historical high of $19.58

    Price 3-year low

    $4.88
    AARD price is currently +149.39% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $263.95M
    AARD market capitalization is $263.95 million

    Market cap 3-year change

    -
    AARD market capitalization 3-year change is unknown

    Market cap All-time high

    $368.88M
    AARD market capitalization is currently -28.45% below its historical high of $368.88 million

    Market cap sector rank

    56.61%
    AARD market capitalization is higher than 56.61% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    AARD shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    AARD shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.23
    AARD beta is 1.23

    200-day SMA

    $10.82
    AARD price is currently +12.48% above its 200-day simple moving average

    50-day SMA

    $11.63
    AARD price is currently +4.64% above its 50-day simple moving average

    RSI

    47.26
    AARD 14-day relative strength index is 47.26

    Volume

    0.59
    AARD 30-day relative volume is 0.59

    ATR

    $0.99
    AARD average true range is $0.99

    10-day Historical Volatility

    42.27%
    AARD 10-day historical volatility is 42.27%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    AARD annual revenue value is unknown

    Revenue Analysts estimate

    -
    AARD annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    AARD annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    AARD annual revenue is unknown

    EPS

    EPS

    -$0.96
    AARD annual earnings per share is -$0.96

    EPS Analysts estimate

    -$2.67
    AARD annual earnings per share is currently -63.94% lower than the consensus analysts' forecast

    EPS 1-year change

    -72.42%
    AARD annual earnings per share is down -72.42% year-on-year

    EPS Sector rank

    56.91%
    AARD annual earnings per share is higher than 56.91% of companies in Healthcare sector

    Profit

    Gross profit

    -
    AARD annual gross profit value is unknown

    Gross margin

    -
    AARD annual gross profit margin value is unknown

    Operating profit

    -$22.67M
    AARD annual operating income is -$22.67 million

    Operating margin

    -
    AARD annual operating profit margin value is unknown

    Net income

    -$20.59M
    AARD annual net profit is -$20.59 million

    Net margin

    -
    AARD annual net profit margin value is unknown

    Expenses

    Total expenses

    $22.67M
    AARD annual total expenses is $22.67 million

    Operating expenses

    $22.67M
    AARD annual total operating expenses is $22.67 million

    Cost of goods sold

    -
    AARD annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $5.30M
    AARD annual SGA is $5.30 million

    Depreciation and amortization

    $16.00K
    AARD annual depreciation & amortization is $16.00 thousand

    Interest expense

    -
    AARD annual interest expense value is unknown

    Income tax

    -
    AARD annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$22.67M
    AARD annual earnings before interest & taxes is -$22.67 million

    EBITDA

    -$22.65M
    AARD annual EBITDA is -$22.65 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $77.51M
    AARD annual total assets is $77.51 million

    Non current assets

    $3.37M
    AARD annual long term assets is $3.37 million

    Current assets

    $74.14M
    AARD annual total current assets is $74.14 million

    Cash and cash equivalents

    $61.64M
    AARD annual cash & cash equivalents is $61.64 million

    Accounts receivable

    -
    AARD annual accounts receivable value is unknown

    Inventory

    -
    AARD annual inventory value is unknown

    Liabilities

    Total liabilities

    $132.15M
    AARD annual total liabilities is $132.15 million

    Long term liabilities

    $127.22M
    AARD annual total long term liabilities is $127.22 million

    Current liabilities

    $4.93M
    AARD annual total current liabilities is $4.93 million

    Accounts payable

    $2.30M
    AARD annual accounts payable is $2.30 million

    Debt

    Total debt

    $779.00K
    AARD annual total debt is $779.00 thousand

    Total debt 1-year change

    +380.86%
    AARD annual total debt is up +380.86% year-on-year

    Long term debt

    $441.00K
    AARD annual long term debt is $441.00 thousand

    Short term debt

    $338.00K
    AARD annual short term debt is $338.00 thousand

    Equity & Capital

    Shareholders equity

    -$54.64M
    AARD annual stockholders equity is -$54.64 million

    Book value

    -$54.64M
    AARD annual book value is -$54.64 million

    Retained earnings

    -$58.33M
    AARD annual retained earnings is -$58.33 million

    Working capital

    $69.21M
    AARD annual working capital is $69.21 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$18.09M
    AARD annual cash flow from operations is -$18.09 million

    Cash from operations 1-year change

    -210.56%
    AARD annual cash flow from operations is down -210.56% year-on-year

    Cash from investing

    -$12.00M
    AARD annual cash flow from investing activities is -$12.00 million

    Cash from investing 1-year change

    -100%
    AARD annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $81.99M
    AARD annual cash flow from financing activities is $81.99 million

    Cash from financing 1-year change

    +100%
    AARD annual cash flow from financing activities is up +100% year-on-year

    CAPEX

    CAPEX

    -
    AARD annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    AARD annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$18.20M
    AARD annual free cash flow is -$18.20 million

    Free cash flow 1-year change

    -212.43%
    AARD annual free cash flow is down -212.43% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    AARD annual gross profit margin value is unknown

    Operating margin

    -
    AARD annual operating profit margin value is unknown

    Net margin

    -
    AARD annual net profit margin value is unknown

    ROA & ROE

    ROA

    -26.56%
    AARD annual return on assets is -26.56%

    ROE

    37.68%
    AARD annual return on equity is 37.68%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AARD price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AARD price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.75
    AARD price to book ratio is 1.75

    PB ratio Sector rank

    52.03%
    AARD price to book ratio is higher than 52.03% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    AARD price to sales ratio value is unknown

    PS ratio Sector rank

    -
    AARD price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $238.17M
    AARD enterprise value is $238.17 million

    Enterprise value Sector rank

    55.92%
    AARD enterprise value is higher than 55.92% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.70
    AARD EV/EBITDA is -7.70

    EV/EBITDA Sector rank

    17.15%
    AARD EV/EBITDA is higher than 17.15% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    15.05
    AARD annual current ratio is 15.05

    Quick ratio

    -
    AARD annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.01
    AARD annual debt to equity ratio is -0.01

    Interest coverage ratio

    -
    AARD annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    AARD piotroski f-score value is unknown

    Altman Z-Score

    -
    AARD altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jun 30, 25 HC Wainwright & Co.
    Buy
    May 15, 25 RBC Capital
    Outperform
    Apr 1, 25 RBC Capital
    Outperform
    Apr 1, 25 Cantor Fitzgerald
    Overweight
    Mar 27, 25 B of A Securities
    Buy
    Mar 10, 25 RBC Capital
    Outperform
    Mar 10, 25 Morgan Stanley
    Overweight
    Mar 10, 25 Cantor Fitzgerald
    Overweight
    Mar 10, 25 B of A Securities
    Buy

    Institutional Ownership

    Screeners with AARD included

    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotechnology industry
    • What is the ticker symbol for Aardvark Therapeutics, Inc.?
    • Does Aardvark Therapeutics, Inc. pay dividends?
    • What sector is Aardvark Therapeutics, Inc. in?
    • What industry is Aardvark Therapeutics, Inc. in?
    • What country is Aardvark Therapeutics, Inc. based in?
    • When did Aardvark Therapeutics, Inc. go public?
    • Is Aardvark Therapeutics, Inc. in the S&P 500?
    • Is Aardvark Therapeutics, Inc. in the NASDAQ 100?
    • Is Aardvark Therapeutics, Inc. in the Dow Jones?
    • When was Aardvark Therapeutics, Inc.'s last earnings report?
    • When does Aardvark Therapeutics, Inc. report earnings?

    What is the ticker symbol for Aardvark Therapeutics, Inc.?

    The ticker symbol for Aardvark Therapeutics, Inc. is NASDAQ:AARD

    Does Aardvark Therapeutics, Inc. pay dividends?

    No, Aardvark Therapeutics, Inc. does not pay dividends

    What sector is Aardvark Therapeutics, Inc. in?

    Aardvark Therapeutics, Inc. is in the Healthcare sector

    What industry is Aardvark Therapeutics, Inc. in?

    Aardvark Therapeutics, Inc. is in the Biotechnology industry

    What country is Aardvark Therapeutics, Inc. based in?

    Aardvark Therapeutics, Inc. is headquartered in United States

    When did Aardvark Therapeutics, Inc. go public?

    Aardvark Therapeutics, Inc.'s initial public offering (IPO) was on February 13, 2025

    Is Aardvark Therapeutics, Inc. in the S&P 500?

    No, Aardvark Therapeutics, Inc. is not included in the S&P 500 index

    Is Aardvark Therapeutics, Inc. in the NASDAQ 100?

    No, Aardvark Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Aardvark Therapeutics, Inc. in the Dow Jones?

    No, Aardvark Therapeutics, Inc. is not included in the Dow Jones index

    When was Aardvark Therapeutics, Inc.'s last earnings report?

    Aardvark Therapeutics, Inc.'s most recent earnings report was on May 14, 2025

    When does Aardvark Therapeutics, Inc. report earnings?

    The next expected earnings date for Aardvark Therapeutics, Inc. is August 29, 2025
    On this page